SFL Q1 2026 Earnings Massive EPS Surprise of 1880 Despite Revenue Uncertainty Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline YUMC Q1 2026 Earnings EPS Miss and Cautious Outlook Weigh on Shares KODK Q1 2026 Earnings Narrowing Losses Amid Ongoing Restructuring LECO Q1 2026 Earnings Narrow EPS Beat Underscores Operational Discipline SRE Q1 2026 Earnings Slight EPS Miss Amid Solid Operational Performance and Positive Market Reaction